Articles by Biodun Awosusi
On the Path to Self-Sufficiency: How Development Agencies Can Support the Local Production of Health Products in Africa
Africa imports 99% of the routine vaccines consumed on the continent, and most sub-Saharan African countries import as much as 70-90% of all medicines used. As Biodun Awosusi at Health Systems and Development Enterprise points out, the ongoing COVID-19 pandemic has shown the risks of this over-dependence on imports for vital health supplies. But fortunately, he says, Africa is moving to increase its domestic manufacturing capabilities for health commodities. He explores how development agencies can support these efforts.
Addressing COVID-19 While Building Long-Term Capacity: Trends and Opportunities in Africa’s Growing Pharmaceutical Markets
The African pharmaceutical market’s estimated worth is between US $40 – $65 billion, but it remains largely untapped, with a heavy reliance on imports. According to Biodun Awosusi at Health Systems and Development Enterprise, the COVID-19 crisis shows the urgent need to unlock new partnerships and investments to accelerate the local production of medical supplies, medicines and vaccines, which could save lives and create jobs. He explores how Africa’s pharmaceutical sector is responding to the pandemic, and how it could be strengthened for the longer term.